News

Depression in pediatric SLE matches average rates


 

FROM LUPUS

The analysis also showed a significant link between higher corticosteroid dose and more symptoms of physical depression and lower self-esteem. The authors found this "not surprising" since the changes in physical appearance associated with higher dose corticosteroids could be expected to lead to issues with self-esteem and depressive symptoms.

The new finding that the prevalence of depression in children and young adults with cSLE matches the general population contrasts with what’s seen in adults with SLE, where the rate of depression exceeds the general adult prevalence. "There may be other factors affecting adults with SLE such as duration, severity or impact of illness, side effects from medications, loss of opportunities, available supports, etc.," Dr. Kohut said. "Further longitudinal research would be needed to clarify such differences in disease."

Dr. Kohut and her associates said that they had no disclosures.

mzoler@frontlinemedcom.com

On Twitter @mitchelzoler

Pages

Recommended Reading

IL-1-beta emerges as key molecule for autoinflammatory diseases
MDedge Rheumatology
Adolescent care transition should begin early
MDedge Rheumatology
New markers, criteria promote earlier intervention in juvenile lupus
MDedge Rheumatology
Self-management programs benefit adolescent arthritis patients
MDedge Rheumatology
Golimumab indication expanded to include ulcerative colitis
MDedge Rheumatology
Joint pain in children rules out JIA
MDedge Rheumatology
The rheumatologist's role in the care of the limping child
MDedge Rheumatology
Adalimumab can serve as first- and second-line biologic in JIA
MDedge Rheumatology
Doppler ultrasound detected synovitis in clinically inactive JIA
MDedge Rheumatology
Earlier biologic use on the rise in juvenile arthritis
MDedge Rheumatology